Skip to main content
Start of content

HESA Committee Meeting

Notices of Meeting include information about the subject matter to be examined by the committee and date, time and place of the meeting, as well as a list of any witnesses scheduled to appear. The Evidence is the edited and revised transcript of what is said before a committee. The Minutes of Proceedings are the official record of the business conducted by the committee at a sitting.

For an advanced search, use Publication Search tool.

If you have any questions or comments regarding the accessibility of this publication, please contact us at

Previous day publication Next day publication

Notice of meeting Amended

Standing Committee on Health (HESA)
42nd Parliament, 1st Session
Meeting No. 66
Wednesday, September 13, 2017, 8:30 a.m. to 6:00 p.m.

8:30 a.m. to 10:30 a.m.
Panel on Household Cultivation of Plants
Anandia Labs
• Jonathan Page, Chief Executive Officer
As an individual
• John Conroy, Barrister
Canadian Federation of Apartment Associations
• John Dickie, President

10:45 a.m. to 12:45 p.m.
Panel on the Age for Legal Possession and Impact on Young Canadians
Canadian Drug Policy Coalition
• Scott Bernstein, Senior Policy Analyst (by videoconference: Vancouver, British Columbia)
Canadian Public Health Association
• Ian Culbert, Executive Director
Canadian Paediatric Society
• Christina Grant, Member of the Adolescent Health Committee
Educators for Sensible Drug Policy
• Judith Renaud, Executive Director
• Paul Renaud, Communications Director
• Peter A. Howlett, President
• Peter Vamos, Executive Director

1:45 p.m. to 3:45 p.m.
Panel on the Age for Legal Possession and Impact on Young Canadians
Canadian Centre on Substance Use and Addiction
• Amy Porath, Director, Research and Policy
Drug Free Kids Canada
• Marc Paris, Executive Director
• William J. Barakett, Member, DFK Canada Advisory Council
Institut national de santé publique du Québec
• Maude Chapados, Scientific Advisor
• François Gagnon, Scientific Advisor

4:00 p.m. to 6:00 p.m.
Panel on Prevention, Treatment, and Low Risk Use
As an individual
• Gabor Maté, Gabor Maté Consulting Ltd. (by videoconference: Vancouver, British Columbia)
Centre for Addiction and Mental Health
• Benedikt Fischer, Senior Scientist, Institute for Mental Health Policy Research
• Bernard Le Foll, Medical Head, Addiction Medicine Service, Acute Care Program (by videoconference: Toronto, Ontario)
City of Toronto
• Eileen de Villa, Medical Officer of Health, Toronto Public Health
As an individual
• Sharon Levy, Director, Adolescent Substance Abuse Program, Boston Children's Hospital (by videoconference: New York, New York)
Amended Section
Ontario Public Health Association
• Michelle Suarly, Chair, Cannabis Task Group
• Elena Hasheminejad, Member, Cannabis Task Group
Clerk of the Committee
David Gagnon (613-995-4108)
2017/09/11 6:47 p.m.